FDA uncover regulatory non-compliance at Cargill plant
Out top story last month, in terms of most traffic, was our report on how US Food and Drug Administration (FDA) had identified problems with some manufacturing practices, hazard analysis and reporting at a Cargill plant in the US.
The US agency outlined, in a letter, how it had identified regulation non-compliance at a Cargill facility in North Carolina after a series of inspections it conducted at the facility in June 2019. The agency was on site after the agri-giant recalled several lots of animal feed for high aflatoxin levels earlier in the year.
The FDA reported that its inspectors found violations of Current Good Manufacturing Practice, Hazard Analysis and Risk-based Preventive Controls for Food for Animals, which caused its products to be adulterated within the meaning of the FD&C Act.
